PhaseRx, Inc.
PZRXQ · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $10 | $11 | $18 | $18 |
| - Cash | $5 | $5 | $7 | $10 |
| + Debt | $5 | $6 | $6 | $6 |
| Enterprise Value | $10 | $12 | $17 | $14 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$3 | -$4 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$4 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.3 | -0.35 | -0.3 |
| % Growth | 20% | 14.3% | -16.7% | – |
| Operating Cash Flow | -$3 | -$3 | -$4 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$3 | -$4 | -$3 |